In March 2025, the company announced new strategies for a direct-to-client offering of its Wegovy weight loss drug. The company founded a brand new pharmacy, identified as NovoCare, which might cost clients $499 per 30 days for use of the drug, lower than fifty percent the cost of the drug by way of other pharmaceutical distribution networks.[53]No